user

Phase I/II trial of bortezimib and pemetrexed in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Natale, R. B.
McKinley, M.
Hilger, J.
Myers, T.
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Aptium Oncol Res Network, Los Angeles, CA USA
[3] Millennium Pharmaceut Inc, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18145
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II Study
    Kawano, Yuko
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Horiike, Atsushi
    Tanimoto, Azusa
    Nishizawa, Hironari
    Ichikawa, Atsuo
    Sakatani, Toshio
    Nakatomi, Katsumi
    Hagiwara, Sachiko
    Ninomiya, Hironori
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2013, 33 (08) : 3327 - 3333
  • [22] Phase II Study of Biweekly Pemetrexed and Gemcitabine in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Barton, John H.
    Patton, Jeffrey F.
    Zubkus, John D.
    Simons, Lisa
    Griner, Paula
    Burris, Howard A., III
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : 841 - 845
  • [23] Phase I Study of Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients with Locally Advanced Non-small Cell Lung Cancer
    Li, B.
    Yi, Y.
    Wang, Z.
    Sun, H.
    Gong, H.
    Zhang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S464 - S465
  • [24] Phase I Study of Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer
    Li, Bao-Sheng
    Gong, He-Yi
    Huang, Wei
    Yi, Yan
    Yu, Jin-Mimg
    Wang, Zhong-Tang
    Zhang, Zi-Cheng
    Sun, Hong-Fu
    Li, Hong-Sheng
    Wang, Li-Ying
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 115 - 119
  • [25] ALK and EGFR mutation analysis in a phase II trial of cisplatin/pemetrexed in Japanese patients with advanced nonsquamous non-small cell lung cancer
    Kaburaki, Kyohei
    Ohyanagi, Fumiyoshi
    Tanimoto, Azusa
    Sakatani, Toshio
    Kawano, Yuko
    Saito, Ryota
    Yanagitani, Noriko
    Kudo, Keita
    Horiike, Atsushi
    Hagiwara, Sachiko
    Motoi, Noriko
    Takeuchi, Kengo
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Pemetrexed monotherapy in patients with advanced non-small cell lung cancer who have had prior chemotherapy: A prospective phase II trial
    Lee, H.
    Ahn, M.
    Ahn, J.
    Kwon, J.
    Lee, S.
    Bae, S.
    Kim, B.
    Kim, H.
    Hong, D.
    Park, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
    Kato M.
    Shukuya T.
    Takahashi F.
    Mori K.
    Suina K.
    Asao T.
    Kanemaru R.
    Honma Y.
    Muraki K.
    Sugano K.
    Shibayama R.
    Koyama R.
    Shimada N.
    Takahashi K.
    BMC Cancer, 14 (1)
  • [28] Phase II trial of oxaliplatin, pemetrexed, and bevacizumab in previously-treated advanced non-small cell lung cancer (NSCLC)
    Heist, R. S.
    Fidias, P.
    Huberman, M.
    Temel, J.
    Sequist, L.
    Lynch, T. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Phase II trial of bevacizumab plus pemetrexed and carboplatin in previously untreated advanced nonsquamous non-small cell lung cancer
    Dalsania, C. J.
    Hageboutros, A.
    Harris, E.
    Krieger, K.
    Vora, C.
    Stevenson, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] The use of pemetrexed in advanced non-small cell lung cancer
    Ng, C.
    Harris, M. A.
    Burt, P. A.
    Sheikh, H. S.
    Lee, L.
    Blackhall, F. H.
    Summers, Y.
    Taylor, P.
    Coote, J.
    Chittalia, A.
    Califano, R.
    Bayman, N.
    LUNG CANCER, 2014, 83 : S12 - S12
12345